denkapparat Operations’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$976K Buy
1,566
+374
+31% +$255K 0.32% 110
2026
Q1
$921K Hold
1,192
0.38% 91
2025
Q4
$920K Buy
1,192
+464
+64% +$315K 0.5% 57
2025
Q3
$409K Buy
+728
New +$412K 0.26% 156
2025
Q2
Sell
-406
Closed -$257K 267
2025
Q1
$257K Buy
+406
New +$279K 0.27% 168

Other funds holding REGN

denkapparat Operations's REGN Position: Q2 2026 in Review

denkapparat Operations increased its Regeneron Pharmaceuticals (REGN) stake by 31% in Q2 2026, buying an estimated $255K and bringing the position to 1,566 shares worth $976K. The position accounts for 0.32% of the portfolio, ranked #110.

denkapparat Operations first reported a position in REGN in Q1 2025 and has held it in 5 quarters since. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • denkapparat Operations held 1,566 shares of Regeneron Pharmaceuticals worth $976K as of Q2 2026.
  • denkapparat Operations bought 374 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $255K.
  • Regeneron Pharmaceuticals made up 0.32% of denkapparat Operations's portfolio in Q2 2026, its #110 holding.
  • denkapparat Operations first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.